Page 54 - Merck Sharp News Today

Using a Test-Negative Case-Control Analysis, Dr Margaret L. Lind and colleagues, investigate the association between primary or booster COVID-19 mRNA vaccination and omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection.

Merck Sharp took Johns Hopkins University to federal court in Maryland on Tuesday over claims that the university secretly obtained patents for inventions based on a collaborative clinical study treating cancer patients with Merck Sharp's Keytruda drug and funding, and then licensing the patents to others in violation of their contract. 

Once Twitter passed out of Leftist control, activist companies and pressure groups sprang into action to chase advertisers off the social media platform.

Elon Musk has namechecked his latest big-name target in Apple CEO Tim Cook as the Tesla boss continues his Twitter war of words.

--Updated Data on Phase 1/2 Trial Evaluating PORT-2 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting-- --Clinical...

Drug Manufacturers to Collaborate with Retail Pharmacies; Atherosclerosis Drugs Sales in Retail Pharmacies to Reach US$ 24 Billion by 2027 Fact.MR's latest analysis on atherosclerosis drugs

Three cases handed down on 17 November 2022 by the EU’s highest court shed important light on the ability of brand owners to oppose the repackaging of medicinal products, particularly...

A patent is a negative, exclusive, transferable right granted to the inventor or to a party to whom an invention has been assigned by the inventor…

/PRNewswire/ -- DelveInsights Glioblastoma Multiforme Market Insights report includes a comprehensive understanding of current treatment practices,...

The glioblastoma multiforme market is expected to witness a significant positive shift owing to the positive outcomes of the several products during the developmental stage by key players such